top of page
News, Events and Updates
Search
Anavex Life Sciences Announces ANAVEX®2-73 Meets Primary and Secondary Endpoints in Clinical Trial
Dec 15, 2020
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application with Expanding Claims
Nov 30, 2020
Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference
Nov 25, 2020
Anavex Life Sciences Presents Proof of Concept Controlled Phase 2 Clinical Trial Data
Nov 6, 2020
Anavex Life Sciences Announces Positive Results from Proof of Concept controlled Phase 2 Trial
Oct 14, 2020
Anavex Life Sciences Announces Completion of ANAVEX®2-73 U.S. Phase 2 Rett Syndrome Clinical Trial
Sep 9, 2020
Anavex Life Sciences to Present at Upcoming Global Healthcare Conferences
Sep 7, 2020
Anavex Life Sciences Announces Commitment for Financial Investment by Shake It Up Foundation
Aug 18, 2020
Anavex Life Sciences Reports Fiscal 2020 3rd Quarter Financial Results And Provides Business Updates
Aug 5, 2020
Anavex Life Sciences Receives TGA Special Access Scheme Approval for ANAVEX®2-73 for Alzheimer’s
Aug 4, 2020
Anavex Life Sciences to Announce Fiscal 2020 Third Quarter Financial Results
Aug 4, 2020
15
16
17
18
19
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
